You are on page 1of 4

Bipolar Disorder in the Elderly: Differential Diagnosis and Treatment | ... http://www.psychiatrictimes.com/print/article/10168/54481?

pageNumber=2

Psychiatric Times. Vol. 24 No. 14

Me gusta

S el primero de tus amigos al que le guste esto.


Previous

Bipolar Disorder in the Elderly: Differential Diagnosis and Treatment


By Nhi-Ha Trinh, MD, MPH and Brent Forester, MD | 1 de diciembre de 2007

Dr Trinh is a geriatric fellow and Dr Forester is medical director of the geriatric neuropsychiatry unit at McLean Hospital in Belmont, Mass, and an instructo speakers' bureau for Pfizer, AstraZeneca, Eli Lilly, Janssen, and Novartis and receives grant support from GlaxoSmithKline and Pfizer.

psychiatry at Harvard Medical School, Boston. Dr Trinh reports no conflicts of interest regarding the subject matter of this article. Dr Forester reports that h

Mood stabilizing anticonvulsants. DVP is effective for the acute treatment of mania in younger adults and appears to be at least modestly e and well-tolerated in elderly patients who are manic.
20,21 22

A mixed-age population of lithium-refractory patients and those who have neurologic

abnormalities appear particularly responsive to DVP.

Some older patients with mania may require higher doses, and measurement of serum

DVP during acute illness and after stabilization is recommended. Toxic adverse effects, including sedation and gait instability, may develop du
23

acute phase and during maintenance therapy. Although hepatic and pancreatic toxicity are infrequent in the elderly, baseline liver functions sh obtained. DVP interacts with other highly protein-bound medications such as warfarin,

is a modest cytochrome P450 enzyme inhibitor, and a

strongly inhibits certain glucuronidation enzymes, thus increasing levels of lamotrigine. Other anticonvulsants have been used in elderly patients who have BD, with limited support from controlled studies. DVP and oxcarbazepine

replaced carbamazepine because of fewer adverse effects and better tolerability, although there is far less efficacy data for treatment of mania

oxcarbazepine. Serum sodium levels should be monitored for patients taking oxcarbazepine because it can cause hyponatremia. Several new anticonvulsants may have more tolerable adverse-effect profiles, including gabapentin, topiramate, tiagabine, zonisamide, lamotrigine, and

. However, as with gabapentin, topiramate and levetiracetam have failed in industry-supported studies of acute mania. Zonisamide still appear

some promise of efficacy in studies of adults with BD. Overall, these newer anticonvulsants have yet to be studied sufficiently in elderly patien and mania to justify an authoritative recommendation for use.

Electroconvulsive therapy. Electroconvulsive therapy (ECT) remains an important intervention in the treatment of acute mania in later life an

reserved for patients whose illness is resistant to medication or who require a rapid symptomatic resolution because of risks of dangerousnes malnutrition. Most responders can then be switched to pharmacotherapeutic maintenance, with or without continued ECT maintenance. treatments may be more effective in mania,
24 25

while unilateral placement may be associated with reduced cognitive disturbance.


5

The co-adm

of ECT and lithium has been associated with increased confusion and should generally be avoided.

Geriatric bipolar depression


Bipolar depression is a complex and difficult-to-treat condition that remains seriously understudied. may increase the risk of mania and rapid cycling over the long-term.
26,27 13

Antidepressants can provide short-term

Minimizing the use of antidepressants in bi- polar depression may be

since some newer mood stabilizers appear to have stronger antidepressant properties than conventional mood stabilizers. The combination of olanzapine and fluoxetine was the first FDA-approved medication for the treatment of bipolar depression,
29 30,31 28

although resea

clinical experience for its use in geriatric BD is limited. Quetiapine was recently approved for bipolar depression in adults. The combination of mood stabilizer, such as lithium or DVP, with an antidepressant is a common and accepted form of treatment.

"Switching" to mania while receiving tricyclic antidepressants (TCAs) and other antidepressant agents can occur in older adults.
32 33

bupropion are favored in younger patients who have bipolar depression to reduce rates of switching. Monoamine oxidase inhibitors (MAOIs) c younger patients with bipolar depression and are effective in older patients with unipolar depression.

In general, TCAs and MAOIs have h

of switching than SSRIs and bupropion, but they have not been studied in geriatric bipolar depression. For a moderate to severe or treatment-refractory episode of major depression, more aggressive pharmacotherapy or ECT is indicated. Highly

1 de 4

22/04/2013 11:17 a.m.

Bipolar Disorder in the Elderly: Differential Diagnosis and Treatment | ... http://www.psychiatrictimes.com/print/article/10168/54481?pageNumber=2

and protracted depressive episodes in BD have not been studied systematically in adult populations or in the elderly. Because of the risk of de

continued morbidity, the physician must make decisions based on clinical judgment or consensus guidelines.29 Some of these measures inclu risperidone34 or venlafaxine plus mirtazapine.35

lowering the dosage or even discontinuing a mood stabilizer; sleep deprivation; ECT; or combination therapies, including tranylcypromine plus

Maintenance treatment
efficacy as maintenance therapy in younger adults,
36

Little information is available regarding maintenance treatment and prevention of subsequent episodes of late-life mania. Lithium has demonst and, although often used for maintenance, DVP has not received an FDA indication for

Lamotrigine, olanzapine, and aripiprazole have been FDA-approved for the prevention of recurrent episodes of bipolar mania and depression. Lamotrigine has been shown to have acute and prophylactic antidepressant effects in patients with acute bipolar depression of bipolar depression.
37 39

and in delaying

Among the major mood stabilizers, lamotrigine stands out as the best-tolerated medication; the only serious adverse e

risk of Stevens-Johnson syndrome. It is attractive for treatment in older adults. Maintenance ECT is an option for patients who show poor resp maintenance medication regimens.10

Psychosocial interventions
A number of studies have demonstrated the efficacy of psychotherapy in improving medication adherence in adult bipolar patients,40-42

not been addressed in the geriatric population. In some promising preliminary studies, interventions in which bipolar patients are taught to mon
46-50

manage stress have been effective in reducing rates of recurrence.43-45 Recent studies have demonstrated the efficacy of family interventions on reducing "expressed emotion," or negative familial attitudes of criticism, hostility, and emotional overinvolvement.

Studies of group interventions over the past 3 decades for patients with BD have yielded positive results, including reduced re-admissions and medication adherence.
41,42,51

Pollack

52

conducted a study of inpatient group treatment for BD with 3 therapeutic goals: sharing information, le
53,54

strategies of coping, and improving interpersonal relationships. Other researchers have reported effective group treatments that include psych education on triggers, confrontation of denial about the illness, and restoration of patients' identity and capacity for intimacy. interpersonal psychotherapy, social rhythm therapy,
43

In addition,

and cognitive-behavioral therapy have demonstrated promising results.

55,56 57

Researchers stress the relative power of combined psychosocial and pharmacological treatments in older adults with depression

compared

form of treatment alone. Gerocognitive behavior therapy combines a developmental perspective with cognitive interventions modified for older This integrative model offers preventive strategies, including management of stress, attention to biological rhythms, and improved medication compliance, as well as reparative measures to deal with the interpersonal, social, and practical aftermath of the manic or depressive episode.

CONCLUSIONS

BD presents complex diagnostic and treatment challenges in later life. Confounding syndromes of delirium and dementia often present difficult

accurate diagnosis. The occurrence of manic symptoms in the older adult must prompt careful evaluation to identify treatable medical conditio Pharmacological approaches and ECT can be helpful in acute and maintenance treatment of late life mania and bipolar depression, although

prospective, randomized, controlled trials in geriatric BD of all phases are currently lacking. Psychotherapy has much to offer in enhancing tre

compliance, addressing relapse risks, and helping patients cope with the implications of a chronic mental disorder. Controlled clinical research

partnership with the technologies of genetics, molecular biology, and functional neuroimaging, will provide a better understanding of the neuro causes of geriatric BD and will promote more specific and effective treatment strategies.
Pages: 1 2

Me gusta

S el primero de tus amigos al que le guste esto.

Join the Conversation

2 de 4

22/04/2013 11:17 a.m.

Bipolar Disorder in the Elderly: Differential Diagnosis and Treatment | ... http://www.psychiatrictimes.com/print/article/10168/54481?pageNumber=2

Email me when someone comments on this article.

Sajatovic M. Treatment of bipolar disorder in older adults. Int J Geriatr Psychiatry. 2002;17:865-873. Young RC, Gyulai L, Mulsant BH, et al. Pharmacotherapy of bipolar disorder in old age: review and recommendations. Am J Geriatr Psychiatry. 2. Weissman MM, Leaf PJ, Tischler GL, et al. Affective disorders in five United States communities. Psychol Med. 1988;18:141-153. 3. Angst J, Sellaro R. Historical perspectives and natural history of bipolar disorder. Biol Psychiatry. 2000;48: 445-457. 4. Yassa R, Nair NP, Iskandar H. Late-onset bipolar disorder. Psychiatr Clin North Am. 1988;11:117-131. 5. Young RC. Bipolar mood disorders in the elderly. Psychiatr Clin North Am. 1997;20:121-136. 1998;3. Available at: http://www.medscape.com/viewarticle/430757. Accessed June 29, 2007. 7. Forester BP, Antognini F, Sivrioglu EY, et al. Geriatric mania. Dir Psychiatry. 2004;24:43-55. hos-pitals, 1972-1988. Am J Psychiatry. 1993;150:1668-1673. 9. Jeste DV, Rockwell E, Harris MJ, et al. Conventional vs newer antipsychotics in elderly patients. Am J Geriatr Psychiatry. 1999;7:70-76. 10. Umapathy C, Mulsant BH, Pollock BG. Bipolar disorder in the elderly. Psychiatr Ann. 2000;30:473-480. Congress of the International Psychogeriatric Association; September 9-14, 2001; Nice, France. 12. Fuller MA, Sajatovic M. Drug Information for Mental Health. Cleveland: Lexi-Comp; 2001. 13. Niedermier JA, Nasrallah HA. Clinical correlates of response to valproate in geriatric inpatients. Ann Clin Psychiatry. 1998;10:165-168. 14. Regenold WT, Prasad M. Uses of intravenous valproate in geriatric psychiatry. Am J Geriatr Psychiatry. 2001;9:306-308. 15. Young RC, Gyulai L, Mulsant BH, et al. Pharmacotherapy of bipolar disorder in old age: review and recommendations. Am J Geriatr Psychiatry. 342-357. 16. Yeung PP, T ariot PN, Schneider LS, et al. Quetiapine for elderly patients with psychotic disorders. Psychiatr Ann. 2000;30:197-201. 17. Goldberg JF. Treatment guidelines: current and future management of bipolar disorder. J Clin Psychiatry. 2000; 61:12-18. 18. Sajatovic M. Treatment of bipolar disorder in older adults. Int J Geriatr Psychiatry. 2002;17:865-873. 19. Nambudiri DE, Meyers BS, Young RC. Delayed recovery from lithium neurotoxicity. J Geriatr Psychiatry Neurol. 1991;4:40-43. 20. McFarland BH, Miller MR, Straumfjord AA. Valproate use in the older manic patient. J Clin Psychiatry. 1990;51: 479-481. 21. Risinger RC, Risby ED, Risch SC. Safety and efficacy of divalproex sodium in elderly bipolar patients. J Clin Psychiatry. 1994;55:215. 1994; 14:311-313. Wilkins, 1992: 310-330. 24. Small JG, Small IF, Milstein V, et al. Manic symptoms: an indication for bilateral ECT. Biol Psychiatry. 1985;20: 125-134. 1987;48: 132-139. 26. Kukopulos A, Reginaldi D, Laddomada P, et al. Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatr

References 1. Weissman MM, Bland RC, Canino GJ, et al. Cross- national epidemiology of major depression and bipolar disorder. JAMA. 1996;276:293-2

6. McDonald WM, Nemeroff CB. Practical guidelines for diagnosing and treating mania and bipolar disorder in the elderly. Medscape Psychiatr Mentl Hea

8. Stoll AL, Tohen M, Baldessarini RJ, et al. Shifts in diagnostic frequencies of schizophrenia and major affective disorders at six North American psychiatr

11. Beyer J, Siegal A, Kennedy J, et al. Olanzapine, divalproex, and placebo treatment non-head-to-head comparisons of older-adult acute mania. Presen

22. Stoll AL, Banov M, Kolbrener M, et al. Neurologic factors predict a favorable valproate response in bipolar and schizoaffective disorders. J Clin Psycho

23. Satlin A, Liptzin B. Diagnosis and treatment of mania. In: Salzman C, ed. Clinical Geriatric Psychopharmacology. 2nd ed. Baltimore: Lippincott William

25. Black DW, Winokur G, Nasrallah A. Treatment of mania: a naturalistic study of electroconvulsive therapy versus lithium in 438 patients. J Clin Psychiat

3 de 4

22/04/2013 11:17 a.m.

Bipolar Disorder in the Elderly: Differential Diagnosis and Treatment | ... http://www.psychiatrictimes.com/print/article/10168/54481?pageNumber=2

Neuropsychopharmakol. 1980;13:156-167. 27. Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry. 1987;144:1403-1411. 2003;60:1079-1088. 29. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry. 1994;151(suppl 12):1-36. 30. Bittman BJ, Young RC. Mania in an elderly man treated with bupropion. Am J Psychiatry. 1991;148:541. 31. Young RC, Jain H, Kiosses DN, Meyers BS. Antidepressant-associated mania in late life. Int J Geriatr Psychiatry. 2003;18:421-424.

28. Tohen M, Vieta E, Calabrese J, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen P

32. Himmelhoch JM, Fuchs CZ, Symons BJ. A double-blind study of tranylcypromine treatment of major anergic depression. J Nerv Ment Dis. 1982;170:6 21:1155-1166. 34. Stoll AL, Haura G. Tranylcypromine plus risperidone for treatment-refractory major depression. J Clin Psychopharmacol. 2000;20:495-496.

33. Georgotas A, McCue RE, Hapworth W, et al. Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly. Biol Psychia

35. Stahl SM. Selecting an antidepressant by using mechanism of action to enhance efficacy and avoid side effects. J Clin Psychiatry. 1998;59(suppl 18) disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry. 2000;57:481-489. 37. Bowden CL, Calabrese JR, Sachs GS, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or patients with bipolar I disorder. Arch Gen Psychiatry. 2003;60:392-400. 38. Vieta E, Goilolea JM. Atypical antipsychotics: newer options for mania and maintenance therapy. Bipolar Disord. 2005;7(suppl 4):21-33. 602 Study Group. J Clin Psychiatry. 1999;60:79-88. 40. Peet M, Harvey N. NIMH workshop report on treatment of bipolar disorder. Psychopharmacol Bull. 1991; 26:409-427. 41. Shakir SA, Volkmar FR, Bacon S, Pfefferbaum A. Group psychotherapy as an adjunct to lithium maintenance. Am J Psychiatry. 1979;136:455-456.

36. Bowden CL, Calabrese JR, McElroy SL, et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with

39. Calabrese JR, Bowden CL, Sachs GS, et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression

42. Volkmar FR, Bacon S, Shakir SA, Pfefferbaum A. Group therapy in the management of manic-depressive illness. Am J Psychother. 1981;35:226-234. disorder protocol. Biol Psychiatry. 1997;41:1165-1173. 44. Frank E, Swartz HA, Mallinger AG, et al. Adjunctive psychotherapy for bipolar disorder: effects of changing treatment modality. J Abnorm Psychol. 579-587. 45. Satterfield JM. Adjunctive cognitive-behavioral therapy for rapid-cycling bipolar disorder: an empirical case study. Psychiatry. 1999;62:357-369.

43. Frank E, Hlastala S, Ritenour A, et al. Inducing lifestyle regularity in recovering bipolar disorder patients: results from the maintenance therapies in bipo

46. Miklowitz DJ, Goldstein MJ, Nuechterlein KH, et al. Family factors and the course of bipolar affective disorder. Arch Gen Psychiatry. 1988;45:225-231 48. Miklowitz DJ, Frank E, George EL. Bipolar Disorder: A Family Focused Treatment Approach. New York: Guilford; 1997. pharmacotherapy. Biol Psychiatry. 2000;48:582-592. 50. Simoneau TL, Miklowitz DJ, Richards JA, et al. Bipolar disorder and family communication: effects of a psychoeducational treatment program. Psychol. 1999;108:588-597. 1977; 47:495-502. 52. Pollack LE. Improving relationships. Groups for inpatients with bipolar disorder. J Psychosoc Nurs Ment Health Serv. 1990;28:17-22. 53. Cerbone M, Mayo JA, Cuthbertson BA, O'Connell RA. Group therapy as an adjunct to medications in the management of bipolar affective disorder. Psychother. 1992;16:174-187. 54. Kanas N. Group psychotherapy with bipolar patients: a review and synthesis. Int J Group Psychother. 1993;43: 321-333. 55. Cochran SD. Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders. J Consult Clin Psychol. 1984;52:873-878. 56. Scott J. Cognitive therapy as an adjunct to medication in bipolar disorder. Br J Psychiatr. 2001;178(suppl 41):S164-S168. 57. Niederebe G. Psychosocial treatments with depressed older adults: a research update. Am J Geriatr Psychiatry . 1996;4(suppl 1):S66-S78. York: Marcel Dekker; 2003. 59. Forester BP, Antognini F, Stoll A. Geriatric bipolar disorder. In: Agronin ME, Maletta GJ, eds. Principles and Practice of Geriatric Psychiatry. Lippincott Williams & Wilkins; 2006:369-391.

47. Miklowitz DJ, Frank E, George EL. New psychosocial treatments for the outpatient management of bipolar disorder. Psychopharmacol Bull. 1996;32:61

49. Miklowitz DJ, Simoneau TL, George EL, et al. Family-focused treatment of bipolar disorder: one-year effects of a psychoeducational program in conjun

51. Davenport YB, Ebert MH, Adland ML, Goodwin FK. Couples group therapy as an adjunct to lithium maintenance of the manic patient. Am J Orthopsych

58. Antognini F. Psychotherapy with depressed older adults. In: Ellison JM, Verma S, eds. Depression in Later Life: A Multidisciplinary Psychiatric Appro

CancerNetwork | ConsultantLive | Diagnostic Imaging | Psychiatric Times | Search Medica | Physicians Practice

1996 - 2010 UBM Medica LLC , a Privacy Statement - Terms of Service - Advertising Information

4 de 4

22/04/2013 11:17 a.m.